Active, not recruitingPHASE1, PHASE2NCT04528680

Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma

Studying Gliosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Northwestern University
Principal Investigator
Roger Stupp, MD, MD
Northwestern University
Intervention
Sonication for opening of blood-brain barrier(device)
Enrollment
57 enrolled
Eligibility
18 years · All sexes
Timeline
2020 – 2025

Study locations (1)

Collaborators

CarThera · Bristol-Myers Squibb · National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04528680 on ClinicalTrials.gov

Other trials for Gliosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Gliosarcoma →

← Back to all trials